Overview
- Editors:
-
-
Yutaka Mishima
-
Mishima Institute for Dermatological Research, Kobe, Japan
Access this book
Other ways to access
Table of contents (126 chapters)
-
Medicine
-
MRI, PET
-
- Kenneth M. Bradshaw, J. Rock Hadley, Martin P. Schweizer, M. Peter Heilbrun, Wayne L. Davis, Gary H. Glover
Pages 849-853
-
Gadolinium NCT, Cf-252 NCT
-
- Koichi Tokuuye, Yasuyuki Akine, Tooru Kobayashi, Keiji Kanda
Pages 855-858
-
- R. Lawaczeck, C.-O. Fischer, U. Krüger, W. Leuther, J. Menrad
Pages 859-864
-
- V. F. Khokhlov, P. N. Yashkin, D. I. Silin, E. S. Djorova, R. Lawaczeck
Pages 865-869
-
- Yosh Maruyama, Carmen Mesina, Jacek Wierzbicki, Arthur T. Porter
Pages 871-875
-
-
Back Matter
Pages 883-920
About this book
There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994.
Editors and Affiliations
-
Mishima Institute for Dermatological Research, Kobe, Japan
Yutaka Mishima